lumbar spinal stenosis
Conditions
Interventions
A needle is used to transplant ADSCs near the degenerated or neuropathy site (intravertebral disc or epidural space). At that time, an echo guide, an X-ray fluoroscope, etc. are used together as neces
Sponsors
Sobajima Satoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients who have been diagnosed with lumbar spinal stenosis and whose affected area can be identified by clinical examinations. - Being 20 years old or older at the time of obtaining consent - No improvement in standard conservative therapy covered by insurance - Do not request surgical treatment at the time of obtaining consent - After receiving sufficient explanation about this research, consent should be obtained in writing from the person himself. - Being able to comply with the set schedule
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will be excluded from this trial. - Patients who have difficulty in subcutaneous liposuction - Patients whose causative lesion is difficult to identify by preoperative examination - Patients with cancer - Patients using anticancer drugs, biopharmacy or immunosuppressants - Patients with active infection - Patients who have received this treatment within 1 month - Patients with serious complications (heart disease, lung disease, liver disease, kidney disease, bleeding tendency, uncontrolled diabetes and hypertension, etc.) that the attending physician or regenerative medicine provider deems inappropriate - Patients with a history of drug hypersensitivity to anesthetics, etc. - Other patients who the doctor in charge deems inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale (VAS), Zurich Claudication Questionnaire (ZCQ), Numeric Rating Scale (NRS), and Roland-Morris Disability Questionnaire (RDQ), JOA score, Neurological examination, MRI and X-ray imaging (1 month, 3months, and 6 months after treatment) | — |
Countries
Japan
Contacts
Public ContactYusuke Harada
Sobajima Clinic
Outcome results
None listed